NCT06163313 Protocol No. 2016 - Calculosis- Endourology;
| NCT ID | NCT06163313 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Calculosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2016-09-17 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15,000 participants in total. It began in 2016-09-17 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Retrospective and prospective study on patients suffering from nephrolithiasis who undergo minimally invasive surgery of the upper excretory system; correlation between the phenotypic and genotypic aspects of the patients and the stone pathology treated with an endoscopic surgical approach.
Eligibility Criteria
Inclusion Criteria: * subjects suffering from kidney stones or tumors of the upper excretory tract \>= 18 years * signature of informed consent Exclusion Criteria: * subjects \< 18 years * presence of mental or physical disability that may prevent the patient from answering the questionnaires.
Contact & Investigator
Andrea Salonia, MD
PRINCIPAL INVESTIGATOR
IRCCS Ospedale San Raffaele
Frequently Asked Questions
Who can join the NCT06163313 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Calculosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06163313 currently recruiting?
Yes, NCT06163313 is actively recruiting participants. Contact the research team at salonia.andrea@hsr.it for enrollment information.
Where is the NCT06163313 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06163313 clinical trial?
NCT06163313 is sponsored by IRCCS San Raffaele. The principal investigator is Andrea Salonia, MD at IRCCS Ospedale San Raffaele. The trial plans to enroll 15,000 participants.